Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting enzymes involved in inflammatory and oncological pathways. Its structure supports high selectivity and binding affinity to specific protein targets, making it valuable in developing drugs for cancer and autoimmune diseases. The compound's fluorinated benzyl group enhances metabolic stability and bioavailability, which are critical for oral drug formulations. It is also explored in structure-activity relationship (SAR) studies to optimize potency and reduce off-target effects in new therapeutic agents.